Not all stem cells are created equal part 7

Stem cell 1


Similarly, in the PERFECT trial (Intramyocardial Transplantation of Bone Marrow Stem Cells for Improvement of Post-Infarct Myocardial Regeneration in Addition to CABG Surgery), patients with ischemic cardiomyopathy received intramyocardial autologous CD133+bone marrow cells or placebo at coronary revascularization surgery. Patient without left ventricle functional improvement after revascularization, regardless of treatment, had lower preprocedural levels of CD133+, CD34+, CD117+ endothelial progenitor cells and thrombocytes, with increased erythropoetin and SH2B3 gene expression in peripheral blood. Responders to CD133+ cell therapy had lower levels of preprocedural vascular endothelial growth factor, erythropoetin, and CXCL10 (C-X-C motif chemokine 10). Using these biomarkers, preprocedural predictive accuracy for responders and nonresponders approximated 80%.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s